ahlam1399
07-21-2015, 10:00 PM
**vavax?s Ebola vaccine shows promise in early-stage trial
(Reuters) - **vavax Inc said its experimental Ebola vaccine induced a substantial immune response to the deadly infection in an early-stage trial involving 230 healthy adults.
http://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/484fd9f6/sc/32/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=7OPcyjFa2Vg:3GlYfOANEGg:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=7OPcyjFa2Vg:3GlYfOANEGg:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=7OPcyjFa2Vg:3GlYfOANEGg:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=7OPcyjFa2Vg:3GlYfOANEGg:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=7OPcyjFa2Vg:3GlYfOANEGg:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/7OPcyjFa2Vg
(Reuters) - **vavax Inc said its experimental Ebola vaccine induced a substantial immune response to the deadly infection in an early-stage trial involving 230 healthy adults.
http://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/484fd9f6/sc/32/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=7OPcyjFa2Vg:3GlYfOANEGg:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=7OPcyjFa2Vg:3GlYfOANEGg:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=7OPcyjFa2Vg:3GlYfOANEGg:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=7OPcyjFa2Vg:3GlYfOANEGg:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=7OPcyjFa2Vg:3GlYfOANEGg:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/7OPcyjFa2Vg